• Recent news

  • Woulgan publication in Sårmagasinet nr. 3 2018

    The woundclinic at Mälersjukehuset in Sweden has tested Woulgan as part of a bigger case study evaluation. Of the 11 wounds evaluated,  9 were completly healed or showed more than a 50% size reduction. The completely healed wounds healed within a 4 week treatment period. The results from this study were compiled and published in Sårmagasinet number 3 2018, authored by…

    Continue reading

Latest presentation

Second quarter 2018 results

Biotec Pharmacon: Results for Q2 2018 (Tromsø, August 16 2018) Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 10.9 million (16.4) in the second quarter of 2018, and a negative EBITDA of NOK 4.2 million (-4.4). ArcticZymes generated sales of NOK 5.7 million during the second quarter whereas Woulgan® generated…

View more